Smith et al demonstrate a significant correlation between miR-106b and Six1 and activated TGFβ (nuclear Smad3), suggesting that high miR-106b leads to increased tumour initiating cell capacity and epithelial to mesenchymal transition [42]. The gene discussed is TGFB1; the disease is neoplasm.